New therapeutic alternatives against leishmaniasis remain a priority. The activity of azithromycin against Leishmania (Leishmania) major has been previously demonstrated.
Krolewiecki, Alejandro J. +5 more
core
Rapid phagosome formation drives parasite control in subclinical <i>Leishmania braziliensis</i> infection. [PDF]
Figueiredo C +9 more
europepmc +1 more source
Oral and Intragastric: New Routes of Infection by Leishmania braziliensis and Leishmania infantum? [PDF]
Reimann MM +6 more
europepmc +1 more source
Vaccination of dogs against Leishmania (Viannia) braziliensis [PDF]
Mayrink, Wilson +9 more
openaire +5 more sources
Selective whole-genome amplification reveals population genetics of Leishmania braziliensis directly from patient skin biopsies. [PDF]
Pilling OA +18 more
europepmc +1 more source
Characterization of GH18 chitinase in Leishmania braziliensis: expression, structural insights, and implications for vaccine and therapeutic development. [PDF]
Rojas-Pirela M +13 more
europepmc +1 more source
Use of liposomal amphotericin B in disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in a pediatric patient with Down syndrome. [PDF]
Sandoval-Juárez A +5 more
europepmc +1 more source
Evaluation of the Antigenic Potential of Epitopes Derived From <i>Leishmania braziliensis</i>. [PDF]
Costa N +7 more
europepmc +1 more source
In vitro and in silico study of an exclusive insertion in the nicotinamide/nicotinate mononucleotide adenylyltransferase from Leishmania braziliensis. [PDF]
Ortiz-Joya LJ +3 more
europepmc +1 more source
Barbituric Acid Derivatives as Covalent Inhibitors of <i>Leishmania braziliensis</i> Dihydroorotate Dehydrogenase. [PDF]
Froes TQ +12 more
europepmc +1 more source

